GlassScriptPhysician profile
Sergio Hernando Pulido
NPI 1770925083
$9,844.74
in general payments reported to CMS, 2019-2025
15 companies · $645 in 2025
The $645 reported for 2025 was less than what a typical Orthopaedic Trauma provider received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,417 · 2020: $449 · 2021: $735 · 2022: $1,425 · 2023: $927 · 2024: $1,247 · 2025: $645.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,818.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,818.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $5,658.66 | 2019-2025 | Gamma, Hoffmann, Axsos |
| Depuy Synthes Sales INC. | $1,664.38 | 2019-2024 | Na, Va-Lcp, Tfn-Advance |
| Smith+Nephew, INC. | $1,460.12 | 2019-2023 | Evos, Trigen Intertan |
| Eclipse Technology Solutions INC. | $215.72 | 2024-2025 | |
| Miach Orthopaedics, INC. | $195.87 | 2025 | |
| Si-Bone, INC. | $160.78 | 2021-2024 | |
| Osteocentric Technologies, INC. | $128.62 | 2022 | |
| Orthofix Medical, INC. | $97.96 | 2019 | |
| Flower Orthopedics Coporation | $88.74 | 2022 | |
| Davol INC. | $45.89 | 2023 | Arista Ah Flexitip |
| Abbott Laboratories | $45.72 | 2022-2023 | Eterna |
| Ethicon US, LLC | $26.72 | 2021 | |
| Peter Brasseler Holdings, LLC | $19.87 | 2023 | |
| Paragon 28, INC. | $18.21 | 2023 | Trauma |
| Kci USA, INC. | $17.48 | 2023 | Prevena, V.A.C.Via |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sergio Pulido listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.